US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 24.680
  • +0.180+0.73%
Close Nov 26 16:00 ET
3.55BMarket Cap-8942P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.000M--
--2024/Q4-- / 11.615M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.000M--
--2024/Q4-- / 11.615M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--

Unlock Free Earnings Estimates

Denali Therapeutics Earnings Reports

  • Denali Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:22 ET

  • Denali Therapeutics | 8-K: Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 6 16:21 ET

  • Denali Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 06:57 ET

  • Denali Therapeutics | 8-K: Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 1 06:51 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data